Patents by Inventor Richard R. Wilson

Richard R. Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210178140
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The ultrasonic catheter system comprises a tubular body having a proximal end, a distal end and a treatment zone located between the distal end and the proximal end, a fluid delivery lumen, at least one ultrasound radiating element positioned in the treatment zone, wiring electrically coupled to the at least one ultrasound radiating element and extending through the tubular body and terminating at a connector, and a control system comprising external circuitry and an isolation pod that is configured to be electrically connected to the connector, the isolation pod being positioned between the tubular body and the external system and comprising an isolation barrier and circuitry for driving the ultrasound radiating element.
    Type: Application
    Filed: February 23, 2021
    Publication date: June 17, 2021
    Applicant: EKOS CORPORATION
    Inventors: RICHARD R. WILSON, ROBERT L. WILCOX, CURTIS GENSTLER, TIM ABRAHAMSON, WM. GERRIT BARRERE, AMY COHEN, GEORGE KEILMAN, LEONARD R. OLIVER, NATALYA PESKIN
  • Patent number: 10926074
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The ultrasonic catheter system comprises a tubular body having a proximal end, a distal end and a treatment zone located between the distal end and the proximal end, a fluid delivery lumen, at least one ultrasound radiating element positioned in the treatment zone, wiring electrically coupled to the at least one ultrasound radiating element and extending through the tubular body and terminating at a connector, and a control system comprising external circuitry and an isolation pod that is configured to be electrically connected to the connector, the isolation pod being positioned between the tubular body and the external system and comprising an isolation barrier and circuitry for driving the ultrasound radiating element.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: February 23, 2021
    Assignee: EKOS CORPORATION
    Inventors: Richard R. Wilson, Robert L. Wilcox, Curtis Genstler, Tim Abrahamson, WM. Gerrit Barrere, Amy Cohen, George Keilman, Leonard R. Oliver, Natalya Peskin
  • Publication number: 20210046313
    Abstract: Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.
    Type: Application
    Filed: July 27, 2020
    Publication date: February 18, 2021
    Inventors: Arnold W. Thornton, Dennis Dong-won Kim, Mark B. Knudson, Katherine S. Tweden, Richard R. Wilson
  • Patent number: 10722714
    Abstract: Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: July 28, 2020
    Assignee: ReShape Lifesciences, Inc.
    Inventors: Arnold W. Thornton, Dennis Dong-won Kim, Mark B. Knudson, Katherine S. Tweden, Richard R. Wilson
  • Publication number: 20190091458
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The ultrasonic catheter system comprises a tubular body having a proximal end, a distal end and a treatment zone located between the distal end and the proximal end, a fluid delivery lumen, at least one ultrasound radiating element positioned in the treatment zone, wiring electrically coupled to the at least one ultrasound radiating element and extending through the tubular body and terminating at a connector, and a control system comprising external circuitry and an isolation pod that is configured to be electrically connected to the connector, the isolation pod being positioned between the tubular body and the external system and comprising an isolation barrier and circuitry for driving the ultrasound radiating element.
    Type: Application
    Filed: August 24, 2018
    Publication date: March 28, 2019
    Inventors: RICHARD R. WILSON, ROBERT L. WILCOX, CURTIS GENSTLER, TIM ABRAHAMSON, WM. GERRIT BARRERE, AMY COHEN, GEORGE KEILMAN, LEONARD R. OLIVER, NATALYA PESKIN
  • Publication number: 20190022393
    Abstract: Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.
    Type: Application
    Filed: May 21, 2018
    Publication date: January 24, 2019
    Inventors: Arnold W. Thornton, Dennis Dong-won Kim, Mark B. Knudson, Katherine S. Tweden, Richard R. Wilson
  • Patent number: 10080878
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The ultrasonic catheter system comprises a tubular body having a proximal end, a distal end and a treatment zone located between the distal end and the proximal end, a fluid delivery lumen, at least one ultrasound radiating element positioned in the treatment zone, wiring electrically coupled to the at least one ultrasound radiating element and extending through the tubular body and terminating at a connector, and a control system comprising external circuitry and an isolation pod that is configured to be electrically connected to the connector, the isolation pod being positioned between the tubular body and the external system and comprising an isolation barrier and circuitry for driving the ultrasound radiating element.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: September 25, 2018
    Assignee: EKOS CORPORATION
    Inventors: Richard R. Wilson, Robert L. Wilcox, Curtis Genstler, Tim Abrahamson, Wm. Gerrit Barrere, Amy Cohen, George Keilman, Leonard R. Oliver, Natalya Peskin
  • Patent number: 9974955
    Abstract: Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: May 22, 2018
    Assignee: ReShape Lifesciences Inc.
    Inventors: Arnold W. Thornton, Dennis Dong-won Kim, Mark B. Knudson, Katherine S. Tweden, Richard R. Wilson
  • Patent number: 9943675
    Abstract: A method of treating an occlusion at a treatment site within a patient's vasculature comprises providing an ultrasonic catheter. The ultrasonic catheter has a distal region, a proximal region opposite the distal region, a fluid delivery lumen having at least one opening in the distal region, and an ultrasound radiating member positioned within the distal region. The method further comprises positioning the ultrasonic catheter at the treatment site, such that at least a portion of the distal region is within the occlusion. The ultrasonic catheter further comprises passing a therapeutic compound through the fluid delivery lumen such that the therapeutic compound is delivered to the treatment site. The ultrasonic catheter further comprises emitting ultrasonic energy from the ultrasound radiating member. The emitted ultrasonic energy has an amplitude that is periodically varied between a low amplitude and a high amplitude.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: April 17, 2018
    Assignee: EKOS CORPORATION
    Inventors: George Keilman, Douglas R. Hansmann, Azita Soltani, Richard R. Wilson
  • Publication number: 20170304615
    Abstract: At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical stimulation includes applying a stimulation signal at the stimulation site. An optional proximal electrical blocking signal is applied to the vagus nerve at a proximal blocking site proximal to the stimulation site. The proximal blocking signal is selected to at least partially block nerve impulses at the proximal blocking site.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 26, 2017
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 9682233
    Abstract: At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical stimulation includes applying a stimulation signal at the stimulation site. An optional proximal electrical blocking signal is applied to the vagus nerve at a proximal blocking site proximal to the stimulation site. The proximal blocking signal is selected to at least partially block nerve impulses at the proximal blocking site.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: June 20, 2017
    Assignee: EnteroMedics Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Patent number: 9655787
    Abstract: A stacked moisture sensing device and urinary continence monitoring system are disclosed. The stacked moisture sensing device has at least a first media-sensor arrangement adjacent to a second media-sensor arrangement. In one embodiment, each of the media-sensor arrangements has a media layer with a first face, a second face and a side edge that extends between the faces wherein the media layers have differing hydrophilicities. Embedded in each media layer is a moisture sensor which can be a wired type tensor or a wireless RFID type sensor. The stacked moisture sensing device can be used in a variety of applications, such as for use in urinary continence monitoring and for use in shipping containers. In urinary continence monitoring applications, a data collection unit can be provided to acquire data from the sensors, which are located in an absorbent undergarment. Methods for locating the sensors within the absorbent undergarment are also disclosed.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: May 23, 2017
    Assignee: Covenant Ministries of Benevolence
    Inventors: Richard R. Wilson, Douglas R. Oudekerk, Douglas P. Wilson, Karla M. Fogel, Rebecca Neth Townsend
  • Patent number: 9616231
    Abstract: A method and apparatus for treating a condition associated with impaired blood pressure and/or heart rate in a subject comprising applying an electrical treatment signal, wherein the electrical treatment signal is selected to at least partially block nerve impulses, or in some embodiments, to augment nerve impulses.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: April 11, 2017
    Assignee: Enteromedics Inc.
    Inventors: Katherine S. Tweden, Richard R. Wilson, Mark B. Knudson, Dennis Dong-Won Kim, Deepak Bhole
  • Patent number: 9591998
    Abstract: Systems and methods for analyzing the gait of an individual are disclosed. The disclosed systems and methods can be configured to acquire data from a first array and a second array of sensors that are configured to be placed in a left and/or right shoe, respectively. The acquired data can be collected or separated into at least two separate gait phases for each array, compared to a baseline condition for each gait phase and categorized into one of at least two uniformity categories for each gait phase. Examples of collected and/or calculated data include pressure values, shear stress values and torque values. The analysis can be focused on both feet of a person, or focused on one foot. A graphical output showing at least one entire gait cycle based on the uniformity categories can then be generated.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: March 14, 2017
    Assignee: Covenant Ministries of Benevolence Inc.
    Inventors: Richard R. Wilson, Douglas R. Oudekerk, Douglas P. Wilson, Karla M. Fogel, Rebecca Neth Townsend
  • Patent number: 9586046
    Abstract: At least one of a plurality of disorders of a patient characterized at least in part by vagal activity innervating at least one of a plurality of organs of the patient is treated by a method that includes positioning an electrode on a vagus nerve. An electrical signal is applied to the electrode to modulate vagal activity by an amount selected to treat the disorder. In some embodiments, the disorder is obesity. The signal may be a blocking or a stimulation signal. In some embodiments, the signal is selected to, at least in part, downregulate neural activity on the vagus nerve.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: March 7, 2017
    Assignee: Enteromedics, Inc.
    Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
  • Publication number: 20170021174
    Abstract: Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.
    Type: Application
    Filed: April 14, 2016
    Publication date: January 26, 2017
    Inventors: Arnold W. Thornton, Dennis Dong-won Kim, Mark B. Knudson, Katherine S. Tweden, Richard R. Wilson
  • Publication number: 20170007815
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The ultrasonic catheter system comprises a tubular body having a proximal end, a distal end and a treatment zone located between the distal end and the proximal end, a fluid delivery lumen, at least one ultrasound radiating element positioned in the treatment zone, wiring electrically coupled to the at least one ultrasound radiating element and extending through the tubular body and terminating at a connector, and a control system comprising external circuitry and an isolation pod that is configured to be electrically connected to the connector, the isolation pod being positioned between the tubular body and the external system and comprising an isolation barrier and circuitry for driving the ultrasound radiating element.
    Type: Application
    Filed: July 11, 2016
    Publication date: January 12, 2017
    Inventors: RICHARD R. WILSON, ROBERT L. WILCOX, CURTIS GENSTLER, TIM ABRAHAMSON, WM. GERRIT BARRERE, AMY COHEN, GEORGE KEILMAN, LEONARD R. OLIVER, NATALYA PESKIN
  • Publication number: 20160302696
    Abstract: Systems and methods for analyzing the gait of an individual are disclosed. The disclosed systems and methods can be configured to acquire data from a first array and a second array of sensors that are configured to be placed in a left and/or right shoe, respectively. The acquired data can be collected or separated into at least two separate gait phases for each array, compared to a baseline condition for each gait phase and categorized into one of at least two uniformity categories for each gait phase. Examples of collected and/or calculated data include pressure values, shear stress values and torque values. The analysis can be focused on both feet of a person, or focused on one foot. A graphical output showing at least one entire gait cycle based on the uniformity categories can then be generated.
    Type: Application
    Filed: June 28, 2016
    Publication date: October 20, 2016
    Inventors: Richard R. Wilson, Douglas R. Oudekerk, Douglas P. Wilson, Karla M. Fogel, Rebecca Neth Townsend
  • Patent number: 9415242
    Abstract: A method of delivery ultrasonic energy and a therapeutic compound to a treatment site and an ultrasonic catheter system are disclosed. The ultrasonic catheter system comprises a tubular body having a proximal end, a distal end and a treatment zone located between the distal end and the proximal end, a fluid delivery lumen, at least one ultrasound radiating element positioned in the treatment zone, wiring electrically coupled to the at least one ultrasound radiating element and extending through the tubular body and terminating at a connector, and a control system comprising external circuitry and an isolation pod that is configured to be electrically connected to the connector, the isolation pod being positioned between the tubular body and the external system and comprising an isolation barrier and circuitry for driving the ultrasound radiating element.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: August 16, 2016
    Assignee: EKOS CORPORATION
    Inventors: Richard R. Wilson, Robert L. Wilcox, Curtis Genstler, Tim Abrahamson, Wm. Gerrit Barrere, Amy Cohen, George Keilman, Leonard R. Oliver, Natalya Peskin
  • Patent number: 9408558
    Abstract: Systems and methods for analyzing the gait of an individual are disclosed. The disclosed systems and methods can be configured to acquire data from a first array and a second array of sensors that are configured to be placed in a left and/or right shoe, respectively. The acquired data can be collected or separated into at least two separate gait phases for each array, compared to a baseline condition for each gait phase and categorized into one of at least two uniformity categories for each gait phase. Examples of collected and/or calculated data include pressure values, shear stress values and torque values. The analysis can be focused on both feet of a person, or focused on one foot. A graphical output showing at least one entire gait cycle based on the uniformity categories can then be generated.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: August 9, 2016
    Assignee: Covenant Ministries of Benevolence Inc.
    Inventors: Richard R. Wilson, Douglas R. Oudekerk, Douglas P. Wilson, Karla M. Fogel, Rebecca Neth Townsend